Labor Lensby LlaMamma

Prenatal Screening and Diagnostic Testing (NIPT, First-Trimester, Amnio, CVS)

The difference between screening (probability) and diagnostic (yes/no) tests, what NIPT can and can't tell you, and how to think about consenting or declining each.

← All topics

What it is

Prenatal testing falls into two buckets: SCREENING tests (probability — 'higher/lower chance of X') and DIAGNOSTIC tests (yes/no — actually testing baby's chromosomes). Screening options include first-trimester combined screen (10–13 weeks: blood + nuchal translucency ultrasound), quad screen (15–22 weeks), and cell-free DNA / NIPT (10+ weeks: sequences placental DNA in your blood). Diagnostic options are CVS (10–13 weeks, placenta sample) and amniocentesis (15+ weeks, amniotic fluid sample) — both carry a small miscarriage risk (~0.1–0.3% in experienced hands) and give definitive answers. All of these are OFFERED; none are required. A 'positive' screen is not a diagnosis. A 'negative' screen doesn't rule out everything.

Evidence review links

Each link opens the full review on the publisher's site in a new tab.

Possible benefits

  • Information — some families want the most information possible, others want lessReview sources ↓
  • Time to prepare (medical planning, emotional support, delivery-hospital choice) if a condition is confirmedReview sources ↓
  • For screening: no procedural risk to the pregnancyReview sources ↓
  • For diagnostic: definitive answers, and access to microarray or whole-exome testing when neededReview sources ↓

Possible risks

  • Screening false positives are common, especially for rare conditions and in younger parents — a 'positive' NIPT for a rare trisomy has a low positive predictive value and needs diagnostic confirmationReview sources ↓
  • NIPT is highly accurate for the common trisomies (21, 18, 13) but LESS accurate for sex chromosomes and microdeletions — commercial marketing overstates thisReview sources ↓
  • CVS and amnio have small but real miscarriage risks (~0.1–0.3%)Review sources ↓
  • Some findings (sex chromosome variations, mosaicism, VUS on microarray) create uncertainty that's hard to sit withReview sources ↓

Alternatives

  • Decline all testing (a real option — pregnancy proceeds the same clinically)Review sources ↓
  • Screening only (most common path)Review sources ↓
  • NIPT + detailed anatomy scan at 18–22 weeks (the modern default in many settings)Review sources ↓
  • Diagnostic testing (CVS or amnio) — usually chosen after a positive screen, family history, or when definitive answers are wantedReview sources ↓
  • Genetic counseling BEFORE testing — often free or covered, and makes results easier to interpretReview sources ↓
Run BRAIN with Labor LensGet Benefits, Risks, Alternatives, Intuition, and Nothing/Wait for Prenatal Screening and Diagnostic Testing (NIPT, First-Trimester, Amnio, CVS) — plus questions for your care team.

Current evidence

ACOG Practice Bulletin 226 and 227 (Screening for Fetal Chromosomal Abnormalities; Prenatal Diagnostic Testing for Genetic Disorders) are the primary sources. Society for Maternal-Fetal Medicine (SMFM) and National Society of Genetic Counselors (NSGC) publish complementary guidance. The 2022 ACOG update endorses offering NIPT to all pregnancies regardless of age, while emphasizing PPV counseling.

Where the evidence is clear · where people may choose differently

For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.

Educational only. Your care team can help you weigh what applies to your specific situation.

Related evidence topics

Questions to ask your care team

  • ?What am I actually being screened for, and what's the positive predictive value for someone like me?
  • ?What would I do differently with the information — and what wouldn't I?
  • ?Can I have genetic counseling before deciding?
  • ?If a screen is positive, what are the next steps — and what if I decline them?
  • ?Can I do the anatomy scan and skip blood screening, or vice versa?
  • ?Is any of this required, or is all of it a choice?

Universal questions (works for any decision)

A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.

  • ?Why are you recommending this now — is it urgent, routine, or optional?
  • ?What happens if we wait an hour (or longer) before deciding?
  • ?What signs would tell us this is working — or that we need to change course?
  • ?What are the alternatives, including doing nothing?
  • ?What would you recommend if this were your family?
  • ?What would change your recommendation?

Sources & provenance

Tap a source to open the original guideline or review in a new tab.

Plain-language paraphrase. Re-verify before publish. This topic should be reviewed by a genetic counselor before publish.

Last reviewed: 2026-07-03

Further reading — canonical references

Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.

Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.

Version history — v1.0.0

  • v1.0.0 · 2026-07-03 · LlaMamma editors

    Initial prenatal testing topic — screening vs diagnostic, NIPT PPV nuance, decline as valid option.

New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.